Nice illustration of the constraints on the genome economy - epigenetic interactions are combinatorially complex, and so determining the consequences of genetic manipulation are incredibly difficult (for now). Market drivers - processor power, algorithm design, cost/genechip parallelism...anything else?? Add a comment...